store at low temperature
store at -80°C
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
説明 | Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death. |
In vitro |
Milatuzumab (5 μg/mL; 8-48 hours) enhanced cell death in MCL cell lines and primary patient tumor cells[1]. In Jeko, Mino, and SP-53 cells, milatuzumab (5 μg/mL; 0.5-2 h) mediated cytotoxicity, depending in part on ROS production and loss of mitochondrial transmembrane potential[1]. Milatuzumab (5 μg/mL; 4 hours) inhibited the NF-κB pathway and induced apoptosis. The mechanism of apoptosis was not related to caspase cleavage, Bcl-2 family member disorder, or autophagy induction[1]. |
In vivo | Administered at a dose of 15 mg/kg/day via intraperitoneal injection every 3 days, milatuzumab significantly increased the survival rate of female SCID mice carrying Jeko cancer cells. Additionally, Milatuzumab and Rituximab demonstrated a synergistic effect in this mouse model[1]. |
別名 | hLL1, MEDI-115 |
分子量 | N/A |
CAS No. | 899796-83-9 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Milatuzumab 899796-83-9 Others MEDI115 hLL1 MEDI-115 MEDI 115 Inhibitor inhibitor inhibit